Maitreya Medicare Ltd (MAITREYA) is currently trading at 120.20 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Maitreya Medicare Limited is a vertically integrated healthcare provider operating hospitals and related healthcare services and products, founded by cardiologist Dr. Narendra Singh Tanwar; it operates hospitals in Surat, Mumbai, Valsad and Nandurbar with an aggregate stated bed capacity of 550 beds and a portfolio of tertiary and quaternary specialities including cardiology, oncology and critical care. The company completed an IPO in November 2023 raising fresh proceeds of ₹14.89 crore that have been fully utilised as disclosed: investments into a subsidiary for the Valsad hospital, redemption of preference shares, working capital and corporate expenses, demonstrating capital allocation directed at expanding hospital footprint and supporting operations. Standalone financials for the half year ended September 30, 2026 show a recovery versus prior periods: revenue sustained above the previous comparable period and the company reported positive profit before tax and positive reported profit from continuing operations, while consolidated results remain loss-making, reflecting group-level absorption of start-up and consolidation costs across subsidiaries. The company’s clinical capability is a differentiator: a premier cath lab, modular superspeciality OTs with laminar airflow, a 20-bed ICU with ECMO and CRRT and scope to introduce organ transplants and robotic surgery in future, positioning Maitreya Medicare Limited to move toward quaternary services as it scales its bed capacity and tertiary offerings.

Over the past 52 weeks, Maitreya Medicare Ltd has traded between a low of ₹103.10 and a high of ₹292.95. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Maitreya Medicare Ltd has a market capitalization of approximately 81.45. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Maitreya Medicare Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 16.49 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 81.45 Cr, Maitreya Medicare Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Maitreya Medicare Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Maitreya Medicare Ltd is 16.49. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Sales were ₹23.7 crore and operating profit was ₹1.6 crore for the half year ended September 2026.